In low-grade gliomas, p16 overexpression is probably related to an oncogene-induced senescence (OIS) phenomenon, which is an antiproliferative response resulting from the activation of the MAPK pathway in the presence of a functional p16 protein. This evidence concerns the gene CDKN2A and glioma.